ANI Pharmaceuticals CFO Stephen Carey Sells 2,850 Shares

What Happened

• Stephen P. Carey, SVP & CFO of ANI Pharmaceuticals (ANIP), sold 2,850 shares in an open-market disposition on September 29, 2026. The weighted average sale price was $73.00 per share, for total proceeds of approximately $208,050. This transaction is reported as a sale (S) and was executed under a pre-established Rule 10b5-1 trading plan.

Key Details

• Transaction date: 2026-09-29
• Prices: weighted average $73.00; individual trade prices ranged $72.57–$73.86
• Total proceeds: ~$208,050
• Transaction type/code: Sale (S); executed pursuant to a 10b5-1 plan adopted March 6, 2026 (footnote)
• Shares owned after transaction: not specified in the provided filing excerpt
• Filing date: 2026-09-30 (timely filing)

Context

• This was a sale under a 10b5-1 trading plan, which is a pre-arranged schedule that allows insiders to sell shares without further executive decision at the time of sale; such sales are often routine and do not necessarily signal a change in the insider’s view of the company.